With plenty of opportunities, China is expected to grow faster than other markets for United Kingdom-based global pharmaceutical company Pharmanovia, said a senior executive in an exclusive interview in Shanghai on Friday. Such continuous growth comes after China had already been the drugmaker’s No 1 market globally since 2023, accounting for roughly 25 percent of … Continue reading Pharmanovia to boost investment in nation